spec sheet11 rows
Thyrotropin-releasing hormone (TRH), whose pharmaceutical form is called protirelin, is a small peptide hormone made by neurons of the hypothalamus. Its best-known role is to signal the pituitary gland to release thyroid-stimulating hormone and prolactin, placing it at the top of the hormonal axis that controls the thyroid. TRH and its more stable analogues have also been studied for effects on mood, alertness, and the nervous system.
- Stimulates thyroid axis
- Arousal and wakefulness
- Antidepressant-like effects
- Neuroprotective in models
- Transient nausea or a brief urge to urinate
- Flushing or a warm sensation
- Short-lived changes in blood pressure
- A brief altered taste has been reported
Overview
Thyrotropin-releasing hormone (TRH) is a hypothalamic releasing hormone and one of the smallest peptide hormones, consisting of just three amino acids joined as pyroglutamyl-histidyl-proline amide [1]. It is produced chiefly by neurons in the paraventricular nucleus of the hypothalamus, although the peptide and its receptors are also found in the brainstem, spinal cord, and several other tissues [2]. Its synthetic counterpart is known by the international name protirelin.
Physiologically, TRH is released into the specialized portal blood vessels that connect the hypothalamus to the anterior pituitary, where it prompts the secretion of thyroid-stimulating hormone and prolactin; through this route it sits at the summit of the hypothalamic-pituitary-thyroid axis [2]. Circulating thyroid hormone in turn feeds back to restrain TRH output, and studies in animals show that destroying the paraventricular nucleus blunts the pituitary response to low thyroid hormone, underscoring that region's central role in the feedback loop [2]. The structure of TRH was worked out in 1969, research that formed part of the study of hypothalamic hormones later recognized with a Nobel Prize [1].
In medicine, protirelin has been used as a diagnostic agent to probe pituitary and thyroid function, although this test has largely been replaced by sensitive assays of thyroid-stimulating hormone [2]. Beyond the endocrine system, TRH acts within the brain as a neuromodulator, and both the natural peptide and longer-acting analogues such as taltirelin have been investigated for effects on arousal, motor function, and neuroprotection [4]. Small controlled studies have reported that delivering TRH directly to the central nervous system can produce rapid, if short-lived, improvement in treatment-resistant depression [3]. Because the natural peptide is broken down quickly and penetrates the brain poorly, much research has focused on stable analogues and improved delivery methods [4].
Mechanism
TRH exerts its effects by binding to TRH receptors, which are G-protein-coupled receptors on the surface of target cells [4]. In the anterior pituitary, this binding stimulates specialized cells to synthesize and release thyroid-stimulating hormone and prolactin, and the resulting thyroid-stimulating hormone then drives the thyroid gland to make its own hormones [2]. Activation of the receptor works largely through the phospholipase C pathway, raising intracellular calcium and engaging protein kinase C to trigger hormone secretion.
The system is governed by negative feedback, since thyroid hormone acts on the and pituitary to suppress both TRH production and the pituitary's responsiveness to it; experiments in which the paraventricular nucleus is lesioned confirm that this hypothalamic center is essential for the normal rise in thyroid-stimulating hormone when thyroid hormone falls [2]. Within the brain itself, TRH behaves as a neuromodulator that can influence arousal, autonomic activity, and neuronal survival, effects that have prompted study of stable analogues in models of brain injury and mood disorder [3][4].
receptor fingerprint
TRH receptor (pituitary)agonist
TRH receptorsagonist
Dopaminergic signalingmodulates
Cholinergic signalingmodulates
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
As the drug protirelin it can cause transient blood pressure changes, flushing, urinary urgency, and a brief odd taste. Because it drives the thyroid and prolactin, it is not something to use casually. Clinical administration is monitored; self-use is risky.
Subjective profileweighing the evidence above
A genuinely interesting neuropeptide with mood and arousal effects, but it is short-lived and clinical rather than something to self-administer casually.
Resources
This entry is here for reference.
Research
- 1969first citedThe identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyrog…
- 1997controlled trialEffects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patie…
- 2023most recentPreclinical In-Vivo Safety of a Novel Thyrotropin-Releasing Hormone-Loaded Biodegradable Nanopa…
- 1.The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide.
- 2.The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion.
- 3.Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients.
- 4.Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice.
- 5.Thyrotropin-releasing hormone time-dependently influences thyrotropin microheterogeneity--an in vivo study in euthyroidism.
- 6.Basal TSH levels compared with TRH-stimulated TSH levels to diagnose different degrees of TSH suppression: diagnostic and therapeutic impact of assay performance.
- 7.Effect of intranasal administration of thyrotropin-releasing hormone on ataxic gait in staggerer mice.
- 8.Preclinical In-Vivo Safety of a Novel Thyrotropin-Releasing Hormone-Loaded Biodegradable Nanoparticles After Intranasal Administration in Rats and Primates.
- 9.Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH).
9 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
What does TRH actually do?
It is the hypothalamic signal that tells the pituitary to release TSH, starting the thyroid cascade, and it also acts on the brain for arousal and mood.
Can it treat depression?
It has shown transient antidepressant-like effects in research, but its short half-life limits practical use.
Why is it so short-acting?
It is rapidly degraded by enzymes, which is why analogs with longer duration have been developed.
Is it a supplement?
No; it is a clinical peptide drug (protirelin) used mainly for pituitary testing.
Adverse effects
- Transient nausea or a brief urge to urinate
- Flushing or a warm sensation
- Short-lived changes in blood pressure
- A brief altered taste has been reported
Notes and cautions
- Generally well tolerated when given for testing
- TRH has been given intranasally in humans, not only in animals. A randomised crossover study in twenty euthyroid volunteers dosed the same people intravenously, nasally and orally, tracking the TSH response over four hours [5], and a separate diagnostic series reports 805 oral and nasal TRH stimulation tests across 409 patients [6]. In mice, intranasal TRH reached blood within five minutes and reduced falls in ataxic animals [7]. Nasal formulation work continues; TRH loaded biodegradable nanoparticles cleared 28 and 42 day safety studies in monkeys and rats [8][9]. What is not established is any modern approved nasal TRH product, or a validated nasal dose for cognitive or mood use; the human nasal record sits almost entirely in endocrine stimulation testing.